Search
Selected Filter
Displaying 191–200 of 244 diseases results
-
In the Press
Round was led by Sofinnova Investments with participation from Abingworth, Lightstone Ventures and all existing investors.
Company expands board of directors and plans to build out team.
-
Don’t Let Others Tell You What You Can’t Do
Beacon StoriesNaheda, a brilliant scientist, has never let her visual impairment stop her from accomplishing her goals and encourages other students with disabilities not to be intimidated by difficult situations. Her story underscores how important it is to ask for help when needed to achieve success.
-
Stargazer Pharmaceuticals Initiates a Phase 2a Clinical Trial for its Stargardt Disease Drug
In the PressThe Foundation Fighting Blindness Retinal Degeneration Fund is an investor in the company
-
Positivity Always Shines Through
Beacon StoriesLinda has been blind since birth, but she never lets her visual impairments stop her from doing what she loves and staying positive through it all.
-
Maeva’s Independence With Her White Cane
Beacon StoriesWe’re celebrating White Cane Awareness Day with spirited 5-year-old Maeva, who is an independent explorer thanks to her white cane.
-
The Dutterers Aren't Afraid to Share Their Story
Beacon StoriesSteve and Dot Dutterer have kind and approachable personalities that captivate everyone they meet. With their expansive network, and a lot of hard work and dedication over the past 19 years, Steve and Dot have raised more than $743,000 for the Foundation through the Baltimore VisionWalk.
-
ProQR Announces Virtual Presentations at Scientific Conferences
ResourceProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced virtual presentations at the Ophthalmology Futures Retina Forum, European Society of Retina Specialists (Euretina) congress and the Annual Meeting of the American Academy of Optometry (AAOpt).
